Multiple lines of evidence link biological, especially respiratory, findings to anxiety disorders (2, 3) and mood disorders (4) . Strategies that involve the use of respiratory challenge tests have been especially fruitful in generating hypotheses about PD (2, 5) and about groups without PD but with a high susceptibility to respiratory-induced panic attacks (3, 4) . The strength of Overbeek and colleagues' study (1) is the inclusion of comorbid PD and MDD as an independent variable. In our trial with a hyperventilation test in PD, MDD, and MDD with panic attacks, we differentiated PD and MDD patients with panic attacks from MDD patients and normal control subjects (3). Our PD patients and control subjects reported similar symptoms, and we observed a similar heart rate, suggesting that PD patients perceive these symptoms to be more aversive, perhaps resulting in a greater likelihood of panic attack.
The issues related to the concept of comorbidity between mood and anxiety disorders are complex and not fully defined (3) . What is of concern from the biological point of view is the real possibility of a biological comorbidity that alters the pathogenesis of some syndromes so as to affect symptoms, diagnosis, and treatment. Investigations into the possible neurobiological abnormalities that might subserve the abnormal subjective response to these provocative agents are clearly worthwhile. One interesting observation from our data was the lower heart-rate response to the hyperventilating challenge test in the MDD group (3). Perhaps this differential response could also be detected in a CO 2 challenge test. In our trial, all groups had an increase in heart rate, but the MDD patients had a significantly lower increase (3). We speculated that, as the anxiety baseline levels were lower in the MDD group before the test, they tended to be less anxious and less responsive to the possible anxiety-inducing symptoms that could occur during the session, because they had never had a panic attack. The patients in the panic groups PD and MDD with panic attacks had a higher level of anticipatory anxiety, and perhaps they might be included in a subgroup of PD patients with a hyperactive response to respiratory tests. Recent studies investigating the complexity of respiratory physiology have revealed consistent irregularities in respiratory pattern, suggesting that these abnormalities may be a vulnerability factor to panic attacks (5) . The source of the high irregularity observed together with unpleasant respiratory sensations in PD patients is still unclear, and different underlying mechanisms might be hypothesized. Panic attacks could be the expression of primal emotion arising from an abnormal modulation of the respiratory or homeostatic functions (5), and provocative tests observing other symptoms besides anxiety symptoms can bring more substantial data to comorbidity research.
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Dear Editor: We thank Dr Nardi for expressing his interest in our work. We are aware that the research of his team is within the same field of respiratory challenges in affective spectrum disorders, especially panic disorder (PD). Although Dr Nardi refers to results of a hyperventilation-provocation study (1) and we reported on the CO 2 challenge, there is a common factor between the 2 procedures: both provoke a disturbance in respiratory homeostasis. As Nardi himself points out, the crucial issue in PD may be a problem of general instability of (cardio) respiratory control mechanisms (2, 3) . If this assumption is correct, other interventions resulting in disturbed respiratory homeostasis, apart from CO 2 challenges, may help to reveal underlying vulnerabilities in PD, as suggested in the case of the hyperventilation-provocation paradigm. Dr Nardi's letter underscores the need for further research in the field of comorbidity and the complex relations of psychiatric syndromes. The Nardi and others study of hyperventilation challenge in PD and MDD showed a comparable reaction of the PD and MDP (MD with panic attacks) group to the hyperventilation challenge (1).
Patients with MDP could be considered as suffering from a less severe variant of PD than patients with MDD plus full diagnostic PD, and therefore, their comparable reaction to a hyperventilation challenge (regarding both reactive panic attacks and heart-rate acceleration) points to a high susceptibility to respiratory challenges, which they have in common with full diagnostic PD patients. This is interesting because Nardi and others' MDP group consists of patients having MD with sporadic panic attacks, whereas in our study we included subjects with full diagnostic PD, either with or without full diagnostic MDD. The observation that a single symptom (sporadic panic attacks) suffices to alter the response to the hyperventilation challenge toward the line of response observed in subjects with the full syndrome suggests a common underlying biological susceptibility. Both studies illustrate that the presence of The Canadian Journal of Psychiatry
